AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma

[1]  B. Vásárhelyi,et al.  Peripheral T(h)1/T(h)2/T(h)17/regulatory T-cell balance in asthmatic pregnancy. , 2011, International immunology.

[2]  Orit Bartov,et al.  A novel dithiol amide CB3 attenuates allergic airway disease through negative regulation of p38 mitogen-activated protein kinase. , 2011, American journal of respiratory and critical care medicine.

[3]  C. Akdis,et al.  Role of Treg in immune regulation of allergic diseases , 2010, European journal of immunology.

[4]  A. Józkowicz,et al.  HIF-1 and HIF-2 transcription factors — Similar but not identical , 2010, Molecules and cells.

[5]  T. Shima,et al.  REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy , 2010, American journal of reproductive immunology.

[6]  E. Crivellato,et al.  Angiogenesis in asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  W. Guo,et al.  Th17 Immunity in Patients with Allergic Asthma , 2009, International Archives of Allergy and Immunology.

[8]  E. Gelfand,et al.  Understanding asthma using animal models , 2009, Allergy, asthma & immunology research.

[9]  K. Austen,et al.  Innate cells and T helper 2 cell immunity in airway inflammation. , 2009, Immunity.

[10]  C. Hawrylowicz,et al.  Regulatory T cells in asthma. , 2009, Immunity.

[11]  D. Robinson.  Regulatory T cells and asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  E. Nozik-Grayck,et al.  A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. , 2009, Free radical biology & medicine.

[13]  Choon-Sik Park,et al.  Tissue Transglutaminase Can Be Involved in Airway Inflammation of Toluene Diisocyanate-Induced Occupational Asthma , 2009, Journal of Clinical Immunology.

[14]  Shailendra Giri,et al.  Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis1 , 2009, The Journal of Immunology.

[15]  Liwu Li,et al.  Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells , 2009, Clinical and experimental immunology.

[16]  L. Young,et al.  AMP‐activated protein kinase: a core signalling pathway in the heart , 2009, Acta physiologica.

[17]  J. Petrie,et al.  AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease , 2009, Clinical science.

[18]  J. Suttles,et al.  Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.

[19]  E. Abraham,et al.  Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[20]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[21]  In-kyu Lee,et al.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. , 2008, Journal of pharmacological sciences.

[22]  Y. Cho,et al.  Five‐aminoimidazole‐4‐carboxamide‐1‐β‐4‐ribofuranoside attenuates poly (I:C)‐induced airway inflammation in a murine model of asthma , 2007, Clinical and Experimental Allergy.

[23]  Andrew Bush,et al.  Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. , 2007, American journal of respiratory and critical care medicine.

[24]  W. Xiong,et al.  Analysis of CD4+CD25+ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma , 2007, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[25]  S. Biswas,et al.  Oxygen Sensing : Life and Death of a Cell Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase , 2007 .

[26]  S. Mahajan,et al.  Effect of Moringa oleifera Lam. Seed Extract on Toluene Diisocyanate-Induced Immune-Mediated Inflammatory Responses in Rats , 2007, Journal of immunotoxicology.

[27]  D. Atlas,et al.  A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. , 2007, Experimental & molecular medicine.

[28]  Young Kyoon Kim,et al.  Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[29]  So Ri Kim,et al.  Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice , 2006 .

[30]  C. Treins,et al.  AMPK activation inhibits the expression of HIF-1α induced by insulin and IGF-1 , 2006 .

[31]  I. Choi,et al.  Epigallocatechin‐3‐gallate protects toluene diisocyanate‐induced airway inflammation in a murine model of asthma , 2006, FEBS letters.

[32]  S. Park,et al.  Antioxidants as novel agents for asthma. , 2006, Mini reviews in medicinal chemistry.

[33]  Moon-Kyu Lee,et al.  Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. , 2006, The Journal of allergy and clinical immunology.

[34]  E. Van Obberghen,et al.  AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1. , 2006, Biochemical and biophysical research communications.

[35]  Shailendra Giri,et al.  5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[36]  Matthew R. Jones,et al.  Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13. , 2005, The Journal of allergy and clinical immunology.

[37]  D. Carling.  AMP-activated protein kinase: balancing the scales. , 2005, Biochimie.

[38]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[39]  R. El Bekay,et al.  Stimulators of AMP‐activated protein kinase inhibit the respiratory burst in human neutrophils , 2004, FEBS letters.

[40]  C. Akdis,et al.  Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells , 2004, The Journal of experimental medicine.

[41]  J. Yoshikawa,et al.  Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. , 2004, American journal of respiratory and critical care medicine.

[42]  E. Goncharova,et al.  Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[43]  J. Malo,et al.  Controversies in epidemiology of occupational asthma , 2003, European Respiratory Journal.

[44]  S. Rennard,et al.  TH2 cytokine-enhanced and TGF-β-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-γ and corticosteroids , 2003 .

[45]  Kai-Uwe Eckardt,et al.  The FASEB Journal express article 10.1096/fj.02-0445fje. Published online December 17, 2002. Widespread, hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs , 2022 .

[46]  S. Rennard,et al.  TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. , 2003, The Journal of allergy and clinical immunology.

[47]  C. Nguyên,et al.  A Small Molecule Inhibitor of Redox-Regulated NF-κB and Activator Protein-1 Transcription Blocks Allergic Airway Inflammation in a Mouse Asthma Model1 , 2002, The Journal of Immunology.

[48]  Yong Chul Lee,et al.  Contribution of Vascular Endothelial Growth Factor to Airway Hyperresponsiveness and Inflammation in a Murine Model of Toluene Diisocyanate-Induced Asthma1 , 2002, The Journal of Immunology.

[49]  D. Hardie,et al.  AMP‐activated protein kinase: the energy charge hypothesis revisited , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[50]  A. Knox,et al.  Human airway smooth muscle cells secrete vascular endothelial growth factor: up‐regulation by bradykinin via a protein kinase C and prostanoid‐dependent mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Pauwels,et al.  Airway eosinophilia is not a requirement for allergen‐induced airway hyperresponsiveness , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[52]  L. Fabbri,et al.  Mechanisms of occupational asthma , 1994, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[53]  P. Barnes,et al.  Haplotype associated with low interleukin-10 production in patients with severe asthma , 1998, The Lancet.

[54]  K. Chung,et al.  Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. , 1998, American journal of respiratory and critical care medicine.

[55]  F. Sundler,et al.  The mouse trap. , 1997, Trends in pharmacological sciences.

[56]  E. Gelfand,et al.  Development of Eosinophilic Airway Inflammation and Airway Hyperresponsiveness in Mast Cell–deficient Mice , 1997, The Journal of experimental medicine.

[57]  Y Fujii-Kuriyama,et al.  A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[59]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[60]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[61]  Ayne,et al.  ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .

[62]  M. Karol,et al.  Animal models of occupational asthma. , 1994, The European respiratory journal.